Skip to content

Total debt at other companies

NeoGenomics logo
NeoGenomicsNEO
$66.29M+5.3%
Veracyte logo
VeracyteVCYT
$39.33M-22.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
Illumina logo
IlluminaILMN
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s total debt?
Personalis, Inc. (PSNL) reported total debt of $39M in Q1 2026.
How has Personalis, Inc.'s total debt changed year-over-year?
Personalis, Inc.'s total debt decreased by 6.2% year-over-year, from $41.58M to $39M.
What is the long-term trend for Personalis, Inc.'s total debt?
Over 5 years (2020 to 2025), Personalis, Inc.'s total debt has grown at a 30.7% compound annual growth rate (CAGR), from $10.99M to $41.96M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.